Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $352,990 - $412,610
-11,000 Reduced 20.3%
43,200 $1.43 Million
Q2 2023

Aug 02, 2023

SELL
$36.12 - $41.79 $505,679 - $585,060
-14,000 Reduced 20.53%
54,200 $1.99 Million
Q1 2023

May 03, 2023

BUY
$39.39 - $51.28 $78,780 - $102,560
2,000 Added 3.02%
68,200 $2.78 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $25,050 - $32,700
600 Added 0.91%
66,200 $3.39 Million
Q3 2022

Nov 04, 2022

SELL
$43.76 - $53.42 $135,656 - $165,602
-3,100 Reduced 4.51%
65,600 $2.87 Million
Q2 2022

Aug 03, 2022

SELL
$46.53 - $55.17 $255,915 - $303,435
-5,500 Reduced 7.41%
68,700 $3.6 Million
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $2.69 Million - $3.33 Million
58,800 Added 381.82%
74,200 $3.84 Million
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $636,328 - $943,250
15,400 New
15,400 $909,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Factorial Partners, LLC Portfolio

Follow Factorial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Factorial Partners, LLC with notifications on news.